© 2003 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ORIGINAL ARTICLE
Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma
1 Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
2 Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Correspondence to:
Correspondence to:
Dr S Tanaka
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University. 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; shinjit{at}surg2.med.kyushu-u.ac.jp
Aim: Angiopoietin 1 (Ang-1) and its antagonist, angiopoietin 2 (Ang-2), are novel ligands that regulate the Tie2 receptor. The Ang-2 gene is upregulated in the hypervascular type of human hepatocellular carcinoma (HCC). To gain a better understanding of the role of the AngTie2 system in HCC the expression of these genes was investigated in a series of human HCCs.
Methods: The expression of the angiopoietin and Tie2 proteins was investigated in nine normal liver tissues and 52 surgically resected HCCs. In addition, the effects of hypoxic stimuli on Ang-1, Ang-2, vascular endothelial growth factor (VEGF), and erythropoietin (EPO) expression was investigated in Hep3B cells.
Results: Ang-1, rather than Ang-2, was more frequently expressed in the normal liver. Ang-1 was expressed in 68% of HCCs, whereas Ang-2 was expressed in 81%, and was significantly higher in poorly differentiated HCCs characterised by high vascularity (p = 0.02), and in tumours with a peliotic change (p = 0.02). Strong expression of Tie2 was seen in tumour vessels in accordance with Ang-2 expression. In Hep3B cells, hypoxic stimuli upregulated VEGF and EPO, but not Ang-1 or Ang-2.
Conclusions: These data support the evidence that the reversal of Ang-1 and Ang-2 expression plays an important role in the angiogenic and dedifferentiation processes in HCC. The hypoxic stimuli were not responsible for Ang-2 upregulation, unlike that of VEGF, in human HCC cells.
Keywords: angiopoietin; Tie2; hypoxia; angiogenesis; hepatocellular carcinoma
Abbreviations: Ang, angiopoietin; EC, vascular endothelial cell; EPO, erythropoietin; HCC, hepatocellular carcinoma; HIF, hypoxia inducible factor; PC, vascular pericyte/smooth muscle cell; PCR, polymerase chain reaction; RT, reverse transcriptase; Tie2, tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2; VEGF, vascular endothelial growth factor
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Szarvas, T., Jager, T., Totsch, M., Vom Dorp, F., Kempkensteffen, C., Kovalszky, I., Romics, I., Ergun, S., Rubben, H.
(2008). Angiogenic Switch of Angiopietins-Tie2 System and Its Prognostic Value in Bladder Cancer. Clin. Cancer Res.
14: 8253-8262
[Abstract] [Full Text] -
Scharpfenecker, M., Fiedler, U., Reiss, Y., Augustin, H. G.
(2005). The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell Sci.
118: 771-780
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
